Overview of comments received on 'Guideline on the clinical investigation of medicinal products for the treatment of attention deficit hyperactivity d

04 August 2010
EMA/CHMP/EWP/12575/2010
Committee for Medicinal Products for Human use (CHMP)
Overview of comments received on 'Guideline on the clinical investigation of medicinal products for the treatment of attention deficit hyperactivity disorder (ADHD)' (EMEA/CHMP/EWP/431734/2008)

download overview:
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/08/WC500095687.pdf